Mkts

Jaguar Health, Inc.

NASDAQ: JAGX
$2.98-0.55 (-15.46%)
As of Oct 19, 2:37 PM ET

Key statistics

Day range
2.953.32
52-week range
2.351,207.50
Today
Open3.24
Previous close2.98
Volume—
Valuation
Market cap6.86M
P/E ratio—
EPS (TTM)-370.63
Income & risk
Dividend / yield—
Beta-0.20
Avg volume1.48M
Discussion

JAGX News

Stories mentioning JAGX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue20,2723,2353,0832,9792,2143,5093,1082,721
Cost of Goods Sold1,1582,200532.00527.00515.00557.00541.00427.00
Gross Profit19,1141,0352,5512,4521,6992,9522,5672,294
Operating Expenses
Research & Development3,92814,3133,6583,2653,7304,5344,0433,653
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)10,182(21,242)(7,238)(8,007)(9,421)(8,157)(7,262)(7,197)
Interest Income
Interest Expense699.00132.006.00(15.00)(56.00)(110.00)(162.00)(108.00)
Other Expense205.00(297.00)(94.00)322.00112.00378.00168.00(729.00)
Pretax Income8,723(23,193)(9,648)(10,560)(10,596)(10,234)(10,021)(9,628)
Tax Provision0.000.000.00
Net Income (Loss)(23,202)(9,502)(10,407)(10,464)(9,920)(9,854)(9,492)
Earnings Per Share (Basic)(13.60)(9.95)(6.28)(10.26)(584.45)(33.63)(26.29)(2.66)
Earnings Per Share (Diluted)(13.60)(9.95)(6.28)(10.26)(584.45)(33.63)(26.29)(2.66)
Weighted Average Shares Outstanding (Basic)516.002,3321,5131,01518.00295.00375.003,573
Weighted Average Shares Outstanding (Diluted)516.002,3321,5131,01518.00295.00375.003,573

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About JAGX

Jaguar Health, Inc. (NASDAQ: JAGX) is a stock listed on the Nasdaq Stock Market under the ticker symbol JAGX. It last traded at $2.98 (Oct 19, 2026, 2:37 PM ET), down 15.5% on the day. That gives Jaguar Health a market capitalisation of $6.9M.

Over the past 52 weeks JAGX has traded between $2.35 and $1,207.50.

Revenue for the quarter ended Mar 31, 2026 was $20.3M. Revenue was up 816% from $2.2M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$20.3M——
Dec 31, 2025$3.2M-$23.2M-717.2%
Sep 30, 2025$3.1M-$9.5M-308.2%
Jun 30, 2025$3.0M-$10.4M-349.3%

From Jaguar Health’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…